Abstract:(4 S )-4-(3-[ 18 F]Fluoropropyl)-L-glutamic acid ([ 18 F]FSPG) is a positron emission tomography (PET) imaging agent for measuring the system x C − transporter activity. It has been used for the detection of various cancers and metastasis in clinical trials. [ 18 F]FSPG is also a promising diagnostic tool for evaluation of multiple sclerosis, drug resistance in chemotherapy, inflammatory brain diseases, and infectious lesions. Due to the very short half-life (110 min) of 18 F nuclide, [ 18 F]FSPG needs to be produced on a daily basis; therefore, fast and efficient synthesis and analytical methods for quality control must be established to assure the quality and safety of [ 18 F]FSPG for clinical use. To manufacture cGMP-compliant [ 18 F]FSPG, all four nonradioactive stereoisomers of FSPG were prepared as reference standards for analysis. (2 S ,4 S )- 1 and (2 R ,4 R )- 1 were synthesized starting from protected L- and D-glutamate derivatives in three steps, whereas (2 S ,4 R )- 1 and (2 R ,4 S )- 1 were prepared in three steps from protected ( S )- and ( R )-pyroglutamates. A chiral HPLC method for simultaneous determination of four FSPG stereoisomers was developed by using a 3-cm Chirex 3126 column and a MeCN/CuSO 4(aq) mobile phase. In this method, (2 R ,4 S )- 1 , (2 S ,4 S )- 1 , (2 R ,4 R )- 1 , and (2 S ,4 R )- 1 were eluted in sequence with sufficient resolution in less than 25 min without derivatization. Scale-up synthesis of intermediates for the production of [ 18 F]FSPG in high optical purity was achieved via stereo-selective synthesis or resolution by recrystallization. The enantiomeric excess of intermediates was determined by HPLC using a Chiralcel OD column and monitored at 220 nm. The nonradioactive precursor with >98% ee can be readily distributed to other facilities for the production of [ 18 F]FSPG. Based on the above accomplishments, cGMP-compliant [ 18 F]FSPG met the acceptance criteria in specifications and was successfully manufactured for human use. It has been routinely prepared and used in several pancreatic ductal adenocarcinoma metastasis-related clinical trials.

Quality control of18F-fluoroestradiol for positron emission tomography

Synthesis and Analysis of Two Versions of Radioisotope Carbon-14 Labelled Dufulin

Preparation Quality Control and Influential Factor of 18F-FDG Using Explora FDG4

Fully Automated Synthesis of 16Α-[18F]fluoro-17-βestrogen Using Explora GN/LC Dual Module

Automated Synthesis of 16Α-[~(18)F]fluoro-17β-estrogen As Estrogen Receptor Imaging Probe of Breast Cancer

Development and validation of a HPLC method for the determination of chemical and radiochemical purity of O-(2-[18F]fluoroethyl-l-tyrosine ([18F]FET)), a PET radiotracer for the imaging of brain tumor

Fully automatic synthesis of [18F]FES for reporter gene hERL expression imaging

Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use

Radiochemicai Yield of 18F-FDG on a CYRIS HM-12 Cyclotron with an F100 Synthetic System

Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design.

Optimization and automation of the radiosynthesis of [18F]Lu-LuFL as a clinically useful PET ligand targeting FAP for tumor imaging

[18F]sufex Click Chemistry Enabled Ultrafast Late-stage Radiosynthesis

Difluorocarbene-enabled synthesis of 18 F-radiotracers in positron emission tomography

The biodistribution and imaging of 16 α-[18F]fluoroestradiol (18F-FES) in rats and breast tumor-bearing nude mice

Simple Column Purification Technique for the Fully Automated Radiosynthesis of 2-[18F] Fluorine-N-(3-bromophenyl)-6,7-dimethoxyquinazoline-4-amine [2-18F-PD153035]

Fully automatic synthesis of [¹⁸F]FES for reporter gene hERL expression imaging.

The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.

Stability and the Improved Methods of 18F-FDG

Long-term quality assurance of [(18)F]-fluorodeoxyglucose (FDG) manufacturing

Radio-synthesis and Mass Spectrometry Analysis of 68Ga-Dkfz-psma-617 for Non-Invasive Prostate Cancer PET Imaging

The regular daily quality control method for the new semiconductor cardiac SPECT